Brief: CK Life Sciences Intl Posts HY Profit Attributable HK$65.1 Million
Aug 2 (Reuters) - CK Life Sciences Intl (Holdings) Inc
0775.HK :
* HY PROFIT ATTRIBUTABLE HK$65.1 MILLION, DECLINE OF 35%
* HY REVENUE HK$2.54 BILLION VERSUS HK$2.64 BILLION
* EXPECTS STRATEGIES ADOPTED IN FIRST HALF IN RESPONSE TO
NEW
MARKET CONDITIONS TO FLOW THROUGH TO RESULTS IN REST OF THE
YEAR
Source text for Eikon: ID:nHKS1bDfRb
Further company coverage: 0775.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CK Life Sciences Intl (Holdings)
See all newsCK Life Sciences H1 loss narrows on lower R&D costs
Brief: CK Life Sciences Intl Announces Resignation Of Lance Richard Lee Yuen As Executive Director, CEO
Brief: CK Life Sciences Intl Logs FY Loss Attributable HK$186.8 Mln
CK Life Sciences rises most in 4 months on advancing cancer vaccine development
Brief: CK Life Sciences Intl Establishes Sequencio Therapeutics For Cancer Vaccine Development